Article Versions Notes

van Setten G-B, Baudouin C, Horwath-Winter J, Böhringer D, Stachs O, Toker E, Al-Zaaidi S, Benitez-del-Castillo JM, Beck R, Al-Sheikh O, et al. The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial. Journal of Clinical Medicine. 2020; 9(11):3536. https://doi.org/10.3390/jcm9113536

van Setten, Gysbert-Botho, Christophe Baudouin, Jutta Horwath-Winter, Daniel Böhringer, Oliver Stachs, Ebru Toker, Sultan Al-Zaaidi, Jose M. Benitez-del-Castillo, Ria Beck, Osama Al-Sheikh, and et al. 2020. "The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial" Journal of Clinical Medicine 9, no. 11: 3536. https://doi.org/10.3390/jcm9113536

van Setten, G. -B., Baudouin, C., Horwath-Winter, J., Böhringer, D., Stachs, O., Toker, E., Al-Zaaidi, S., Benitez-del-Castillo, J. M., Beck, R., Al-Sheikh, O., Seitz, B., Barabino, S., Reitsamer, H. A., & Müller-Lierheim, W. G. K. (2020). The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial. Journal of Clinical Medicine, 9(11), 3536. https://doi.org/10.3390/jcm9113536